UBS Group’s Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share GLEO.WS Stock Holding History

UBS Group’s Portfolio GLEO.WS Stock Details GLEO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,687	Closed	-$5K	–	10641
2021 Q2	$5K	Sell	4,687 -8,380	-64%	-$8.24K	﹤0.01%	8633
2021 Q1	$7K	Buy	+13,067	New	+$12.2K	﹤0.01%	8199

Other funds holding GLEO.WS

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

UBS Group's GLEO.WS Position: Q3 2021 in Review

UBS Group sold out of Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share (GLEO.WS) in Q3 2021, closing a stake of 4,687 shares — an estimated $5K sold.

UBS Group first reported a position in GLEO.WS in Q1 2021 and held it in 2 quarters. The position peaked at $7K in Q1 2021. 2 funds tracked by Wall St. Rank hold GLEO.WS as of Q3 2021.

UBS Group reported no remaining Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share position as of Q3 2021 after selling out during the quarter.
UBS Group sold 4,687 Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share shares in Q3 2021, an estimated $5K.
UBS Group first reported a position in Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share in Q1 2021 and held it in 2 quarters.
UBS Group's Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share position peaked at $7K in Q1 2021.
2 funds tracked by Wall St. Rank held Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.